← FDA DRUG APPROVALS

FDA ANDA · ANDA206667

PENTAMIDINE ISETHIONATE

Sponsor: PAI HOLDINGS

APPLICATION
ANDA206667
TYPE
ANDA
ORIGINAL APPROVAL
2019-04-24
LATEST ACTION
2019-04-24
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription

Products

PENTAMIDINE ISETHIONATEPrescription
PENTAMIDINE ISETHIONATE 300MG/VIAL · FOR SOLUTION · INHALATION

Approval history

2019-04-24UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →